A Longer Duration of Intravenous Antibiotic Treatment for Patients with Early Periprosthetic Joint Infections Is Not Associated with a Lower Failure Rate

Background: In recent years, many studies have demonstrated the efficacy of an early switch to oral antibiotics after surgical treatment in orthopedic-related infections. However, large analyses on periprosthetic joint infections (PJIs) are lacking. Material and Methods: We conducted a retrospective...

Full description

Saved in:
Bibliographic Details
Main Authors: Janneke Meijer, Alex Soriano, Wierd Zijlstra, Bas ten Have, Saad Tarabichi, Paul Jutte, Javad Parvizi, Marjan Wouthuyzen-Bakker
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/14/1/79
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589368212062208
author Janneke Meijer
Alex Soriano
Wierd Zijlstra
Bas ten Have
Saad Tarabichi
Paul Jutte
Javad Parvizi
Marjan Wouthuyzen-Bakker
author_facet Janneke Meijer
Alex Soriano
Wierd Zijlstra
Bas ten Have
Saad Tarabichi
Paul Jutte
Javad Parvizi
Marjan Wouthuyzen-Bakker
author_sort Janneke Meijer
collection DOAJ
description Background: In recent years, many studies have demonstrated the efficacy of an early switch to oral antibiotics after surgical treatment in orthopedic-related infections. However, large analyses on periprosthetic joint infections (PJIs) are lacking. Material and Methods: We conducted a retrospective observational multicenter study in patients diagnosed with an early post-operative PJI, defined as one occurring <3 months after the index arthroplasty and treated with debridement, antibiotics, and implant retention (DAIR). Patients from Europe and the USA were included. We took advantage of the fact that an early oral antibiotic switch is routine practice in Europe as opposed to a long duration of intravenous (IV) antibiotic treatment in the USA. Failure was defined as the clinical need for (i) a second unintended DAIR procedure, (ii) implant removal, (iii) suppressive antibiotic treatment, or (iii) PJI-related death, all within one year after DAIR. Results: A total of 668 patients were included. A total of 277 received IV antibiotics for <14 days, 232 between 14 and 27 days, and 159 for >27 days. The overall 1-year failure rate within the 3 groups was 41.5%, 44.4%, and 42.1%, respectively (<i>p</i> = 0.80). This observation remained when excluding patients who failed during IV therapy. A longer duration of IV therapy seemed beneficial for those patients with a high pre-operative C-reactive protein level and lack of modular component exchange. Conclusions: In early post-operative PJIs, a longer duration of IV therapy is not associated with a lower failure rate but may be continued until a sufficient bacterial load reduction has been achieved.
format Article
id doaj-art-f21463b0034545bb8d06c1b4d5b02226
institution Kabale University
issn 2079-6382
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj-art-f21463b0034545bb8d06c1b4d5b022262025-01-24T13:18:53ZengMDPI AGAntibiotics2079-63822025-01-011417910.3390/antibiotics14010079A Longer Duration of Intravenous Antibiotic Treatment for Patients with Early Periprosthetic Joint Infections Is Not Associated with a Lower Failure RateJanneke Meijer0Alex Soriano1Wierd Zijlstra2Bas ten Have3Saad Tarabichi4Paul Jutte5Javad Parvizi6Marjan Wouthuyzen-Bakker7Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The NetherlandsDepartment of Infectious Diseases, Hospital Clinic of Barcelona, University of Barcelona, 08036 Barcelona, SpainDepartment of Orthopaedic Surgery, Medical Center Leeuwarden, Henri Dunantweg 2, 8934 AD Leeuwarden, The NetherlandsDepartment of Orthopaedic Surgery, Martini Hospital, Van Swietenplein 1, 9728 NT Groningen, The NetherlandsDepartment of Orthopaedic Surgery, Rothman Institute, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USADepartment of Orthopaedic Surgery, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The NetherlandsInternational Joint Center, Acibadem University Hospital, 34303 Istanbul, TurkeyDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The NetherlandsBackground: In recent years, many studies have demonstrated the efficacy of an early switch to oral antibiotics after surgical treatment in orthopedic-related infections. However, large analyses on periprosthetic joint infections (PJIs) are lacking. Material and Methods: We conducted a retrospective observational multicenter study in patients diagnosed with an early post-operative PJI, defined as one occurring <3 months after the index arthroplasty and treated with debridement, antibiotics, and implant retention (DAIR). Patients from Europe and the USA were included. We took advantage of the fact that an early oral antibiotic switch is routine practice in Europe as opposed to a long duration of intravenous (IV) antibiotic treatment in the USA. Failure was defined as the clinical need for (i) a second unintended DAIR procedure, (ii) implant removal, (iii) suppressive antibiotic treatment, or (iii) PJI-related death, all within one year after DAIR. Results: A total of 668 patients were included. A total of 277 received IV antibiotics for <14 days, 232 between 14 and 27 days, and 159 for >27 days. The overall 1-year failure rate within the 3 groups was 41.5%, 44.4%, and 42.1%, respectively (<i>p</i> = 0.80). This observation remained when excluding patients who failed during IV therapy. A longer duration of IV therapy seemed beneficial for those patients with a high pre-operative C-reactive protein level and lack of modular component exchange. Conclusions: In early post-operative PJIs, a longer duration of IV therapy is not associated with a lower failure rate but may be continued until a sufficient bacterial load reduction has been achieved.https://www.mdpi.com/2079-6382/14/1/79periprosthetic joint infectionantibioticsintravenousoralDAIR
spellingShingle Janneke Meijer
Alex Soriano
Wierd Zijlstra
Bas ten Have
Saad Tarabichi
Paul Jutte
Javad Parvizi
Marjan Wouthuyzen-Bakker
A Longer Duration of Intravenous Antibiotic Treatment for Patients with Early Periprosthetic Joint Infections Is Not Associated with a Lower Failure Rate
Antibiotics
periprosthetic joint infection
antibiotics
intravenous
oral
DAIR
title A Longer Duration of Intravenous Antibiotic Treatment for Patients with Early Periprosthetic Joint Infections Is Not Associated with a Lower Failure Rate
title_full A Longer Duration of Intravenous Antibiotic Treatment for Patients with Early Periprosthetic Joint Infections Is Not Associated with a Lower Failure Rate
title_fullStr A Longer Duration of Intravenous Antibiotic Treatment for Patients with Early Periprosthetic Joint Infections Is Not Associated with a Lower Failure Rate
title_full_unstemmed A Longer Duration of Intravenous Antibiotic Treatment for Patients with Early Periprosthetic Joint Infections Is Not Associated with a Lower Failure Rate
title_short A Longer Duration of Intravenous Antibiotic Treatment for Patients with Early Periprosthetic Joint Infections Is Not Associated with a Lower Failure Rate
title_sort longer duration of intravenous antibiotic treatment for patients with early periprosthetic joint infections is not associated with a lower failure rate
topic periprosthetic joint infection
antibiotics
intravenous
oral
DAIR
url https://www.mdpi.com/2079-6382/14/1/79
work_keys_str_mv AT jannekemeijer alongerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT alexsoriano alongerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT wierdzijlstra alongerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT bastenhave alongerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT saadtarabichi alongerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT pauljutte alongerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT javadparvizi alongerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT marjanwouthuyzenbakker alongerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT jannekemeijer longerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT alexsoriano longerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT wierdzijlstra longerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT bastenhave longerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT saadtarabichi longerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT pauljutte longerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT javadparvizi longerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate
AT marjanwouthuyzenbakker longerdurationofintravenousantibiotictreatmentforpatientswithearlyperiprostheticjointinfectionsisnotassociatedwithalowerfailurerate